| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |